[Summary] Antibiotic API
Chuanning Bio is affiliated with Kelun Group, which was founded in 1996 and has now formed a 'pin' shaped operating platform consisting of Kelun Pharma, Chuanning Bio, and Kelun-Biot, with a total market value exceeding 100 billion yuan. In 2023, Kelun ranked among the top three pharmaceutical manufacturers in China. Kelun has applied for more than 1,300 invention patents and obtained over 700 invention patent authorizations, becoming a leading enterprise in China's generic drug industry.
Yili Chuanning Biotechnology Co., Ltd. was established in December 2010. The Chuanning Bio project covers an area of 1,319 mu. Its main products include thiocyanate erythromycin, cephalosporin, penicillin and other antibiotic intermediates, as well as high-end APIs such as UDCA and coenzyme Q10, with a total annual production capacity of over 16,000 tons. The company has established a post-doctoral research workstation, a demonstration base for industry-university-research joint training of graduate students, and an academician collaborative innovation center, cumulatively undertaking 45 science and technology projects at the national, autonomous region, and Yili Prefecture levels. As of April 2024, it has been granted 68 patents, including 32 invention patents.
What does Yili Chuanning Biotechnology Co., Ltd. require? Who is Chuanning Bio hiring? Chuanning Bio recruitment: 生物/制药/化工/环保类占比最多占20.1%,其次是销售类占16.5%. What education can get in at Chuanning Bio? 本科占比最多占53%,其次是不限占25%. High education required at Chuanning Bio? 硕士占3.7%,博士占3.7%. Work experience required at Chuanning Bio? 不限占比最多占62.8%,其次是3-5年占14%. Where are the job locations at Chuanning Bio? 伊犁占比最多占74.4%,其次是上海占21.3%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows